ATE246708T1 - Elatase-inhibitoren - Google Patents

Elatase-inhibitoren

Info

Publication number
ATE246708T1
ATE246708T1 AT95918993T AT95918993T ATE246708T1 AT E246708 T1 ATE246708 T1 AT E246708T1 AT 95918993 T AT95918993 T AT 95918993T AT 95918993 T AT95918993 T AT 95918993T AT E246708 T1 ATE246708 T1 AT E246708T1
Authority
AT
Austria
Prior art keywords
inhibitors
elatase
elastase
compounds
human neutrophil
Prior art date
Application number
AT95918993T
Other languages
English (en)
Inventor
William A Metz Jr
Steven L Gallion
Joseph P Burkhart
Michael R Angelastro
Norton P Peet
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Application granted granted Critical
Publication of ATE246708T1 publication Critical patent/ATE246708T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Genetics & Genomics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Hematology (AREA)
  • Pulmonology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT95918993T 1994-06-02 1995-05-05 Elatase-inhibitoren ATE246708T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25279994A 1994-06-02 1994-06-02
PCT/US1995/005618 WO1995033763A1 (en) 1994-06-02 1995-05-05 Novel elastase inhibitors

Publications (1)

Publication Number Publication Date
ATE246708T1 true ATE246708T1 (de) 2003-08-15

Family

ID=22957608

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95918993T ATE246708T1 (de) 1994-06-02 1995-05-05 Elatase-inhibitoren

Country Status (20)

Country Link
EP (1) EP0804465B1 (de)
JP (1) JP3623799B2 (de)
KR (1) KR100347285B1 (de)
CN (1) CN1149877A (de)
AT (1) ATE246708T1 (de)
AU (1) AU689589B2 (de)
CA (1) CA2189527C (de)
DE (1) DE69531459T2 (de)
DK (1) DK0804465T3 (de)
ES (1) ES2199992T3 (de)
FI (1) FI964781L (de)
HU (1) HU221197B1 (de)
IL (1) IL113940A (de)
NO (1) NO965097L (de)
NZ (1) NZ285565A (de)
PT (1) PT804465E (de)
SI (1) SI0804465T1 (de)
TW (1) TW403762B (de)
WO (1) WO1995033763A1 (de)
ZA (1) ZA954430B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU690986B2 (en) * 1994-06-02 1998-05-07 Merrell Pharmaceuticals Inc. Perfluoroalkyl ketone inhibitors of elastase and processes for making the same
NZ287604A (en) * 1994-06-02 1998-12-23 Merrell Pharma Inc Acylated enol derivatives as prodrugs of elastase inhibitors
US5948886A (en) * 1996-11-20 1999-09-07 Hoechst Marion Roussel, Inc. Acylated enol derivatives of α-ketoesters and α-ketoamides
US6172044B1 (en) 1995-12-01 2001-01-09 Aventis Pharmaceuticals Inc. Acylated enol derivative of α-ketoesters and α-ketoamides
US6767991B1 (en) 1997-08-11 2004-07-27 Boehringer Ingelheim (Canada) Ltd. Hepatitis C inhibitor peptides
CL2004001161A1 (es) 2003-05-21 2005-04-08 Boehringer Ingelheim Int Compuestos describe compuestos derivados de quinolina; composicion farmaceutica; y su uso para tratar una enfermedad causada por el virus de la hepatitis c.
JP4914355B2 (ja) 2004-07-20 2012-04-11 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｃ型肝炎インヒビターペプチド類似体
UY29016A1 (es) 2004-07-20 2006-02-24 Boehringer Ingelheim Int Analogos de dipeptidos inhibidores de la hepatitis c
EP2027143A2 (de) 2006-05-23 2009-02-25 Irm Llc Verbindungen und zusammensetzungen als kanalaktivierende protease-hemmer
CA2677487A1 (en) * 2007-02-09 2008-08-14 Irm Llc Compounds and compositions as channel activating protease inhibitors
AU2020349353A1 (en) 2019-09-17 2022-04-14 Duke University Alvelestat for use in the treatment of graft rejection, bronchiolitis obliterans syndrome and graft versus host disease
HUE064089T2 (hu) 2020-04-16 2024-02-28 Mereo Biopharma 4 Ltd Alvelesztat neutrofil elasztáz inhibitort alkalmazó módszerek alfa-1-antitripszin hiány által közvetített légzõszervi megbetegedés kezelésére
AU2022373971A1 (en) 2021-10-20 2024-04-04 Mereo Biopharma 4 Limited Neutrophil elastase inhibitors for use in the treatment of fibrosis

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8600263D0 (en) * 1985-01-22 1986-02-12 Ici America Inc Peptide derivatives
ATE71934T1 (de) * 1985-06-07 1992-02-15 Ici America Inc Selektionierte difluorverbindungen.
ZA905737B (en) * 1989-07-26 1991-05-29 Merrell Dow Pharma Novel peptidase inhibitors
JPH06504547A (ja) * 1990-12-28 1994-05-26 ジョージア・テック・リサーチ・コーポレーション ペプチドケトアミド、ケト酸およびケトエステル
ZA926185B (en) * 1991-08-22 1993-03-01 Merrell Dow Pharma Novel orally-active elastase inhibitors.

Also Published As

Publication number Publication date
IL113940A0 (en) 1995-08-31
HUT76926A (hu) 1998-01-28
AU689589B2 (en) 1998-04-02
NO965097D0 (no) 1996-11-29
DK0804465T3 (da) 2003-11-24
NO965097L (no) 1997-01-31
WO1995033763A1 (en) 1995-12-14
EP0804465A1 (de) 1997-11-05
CN1149877A (zh) 1997-05-14
HU221197B1 (en) 2002-08-28
CA2189527C (en) 2000-12-19
MX9606030A (es) 1998-05-31
DE69531459D1 (de) 2003-09-11
SI0804465T1 (en) 2003-12-31
DE69531459T2 (de) 2004-06-24
IL113940A (en) 1999-12-31
AU2470995A (en) 1996-01-04
JP3623799B2 (ja) 2005-02-23
ZA954430B (en) 1996-02-13
FI964781A7 (fi) 1997-01-29
ES2199992T3 (es) 2004-03-01
TW403762B (en) 2000-09-01
KR100347285B1 (ko) 2003-01-15
JPH10500992A (ja) 1998-01-27
FI964781A0 (fi) 1996-11-29
FI964781L (fi) 1997-01-29
CA2189527A1 (en) 1995-12-14
NZ285565A (en) 1998-08-26
EP0804465B1 (de) 2003-08-06
HU9603312D0 (en) 1997-01-28
PT804465E (pt) 2003-12-31

Similar Documents

Publication Publication Date Title
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
TR199901905T2 (xx) 2-(P�rin-9-il)-tetrahidrofuran-3,4-diol t�revleri.
NO307968B1 (no) Pyrazolo- og pyrrolopyridiner og farmasøytisk blanding derav
BG101841A (bg) Инхибитори на клетъчна адхезия
DK0793674T3 (da) Inhibitorer af human neutrofil elastase
PT695758E (pt) Amidas e esteres de pentapeptidos inibidores de cancro humano
PT1028954E (pt) Imidazoles substituidos uteis no tratamento de doencas inflamatorias
BR9710737A (pt) Pentafluorobenzenosulfonamidas e análogos.
ES2192839T3 (es) Timosina beta 4 oxidada.
DE69531459D1 (de) Elatase-inhibitoren
DK0489877T3 (da) Antiatherosklerotiske og antithrombotiske 2-amino-6-phenyl-4H-pyran-4-oner
AP2000001761A0 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase.
ATE265455T1 (de) Tetrahydropyridoverbindungen
ES2140672T3 (es) Compuestos biciclicos sustituidos, fusionados y puentes utilizados como agentes terapeuticos.
TR200001026T2 (tr) Nötrofil elastaz inhibitörü olarak pirolopirolon türevleri.
BRPI0415355A (pt) triarilimidazóis
NO20005548L (no) Mykobakterieinhibitorer
DE69726743D1 (de) Peptid analoge, die einen siebengliedrigen lactamring enthalten
EA200100152A1 (ru) Замещенные пиперазиноны и их терапевтическое применение
EA199800822A1 (ru) Способ лечения избыточной агрессии
TR200003083T2 (tr) CNS hastalıklarının tedavisi için paroxetine 10-camphorsulfonate.
DE69010897D1 (de) Verwendung von monoklonalen Antikörpern gegen B2-Mikroglobulin.
MX9606031A (es) Inhibidores de cetona perfluoroalquilica de elastasa y procesos para fabricarlos.
PE61999A1 (es) Compuestos de tetrahidropiridina

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0804465

Country of ref document: EP

REN Ceased due to non-payment of the annual fee